Zetagen Therapeutics has filed a notice of an exempt offering of securities to raise $15,000,000.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, Zetagen Therapeutics is raising $15,000,000.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, David Tischler played a key role in…